Cure
Overview
Ten firms writing checks into women's health in 2026, from menopause and cardiovascular care to bone density, autoimmune disease, and oncology.
The women's health gap could add $1 trillion to the global economy every year by 2040, with roughly $3 in economic growth for every $1 invested. For years, the market was treated as a niche. Today it's valued at $430–$440 billion globally, projected to surpass $600 billion by 2030, and the capital is moving to match it.
Naseem Sayani, Director of the Innovator's Circle at Women's Health Access Matters (WHAM), Venture Partner at Zero Limits Capital, The Sparrow Fund, an Advisor at Tower Capital, and host of The Capital Flex podcast, sees a turning point driven less by sentiment than by the numbers. "The health of women is massive, proven, and fundable," she says. "If investors and founders reframe the narrative around financial opportunity paired with the conditions that affect women most, we can capture the next $100B in exits while delivering high human impact." Sayani deliberately says the health of women rather than women's health—a reframe meant to move past the stigma the older phrase still carries and toward the full scale of the opportunity.
“Great companies I am tracking include Forela Health, Lera Health, Omniscience Bio, and EXO Technologies, each solving from a different lens, including autoimmune conditions, functional medicine, and new core infrastructure that rebuilds how we deliver clinical trials and how we capture and surface insights,” Sayani says. "The investors investing in this category are reshaping the healthcare landscape in ways that will fundamentally change how healthcare works for half the population, from the science to the clinic, across her lived experience."
Women’s health funds increasingly organize their theses around conditions that affect women exclusively (menopause, endometriosis, gynecologic cancers), differently (cardiovascular disease, Alzheimer's), and disproportionately (autoimmune disease, osteoporosis, mental health conditions).
Below are ten firms funding the health of women in 2026.
1. Foreground Capital
Stage focus: Seed, Series A Check size range: ~$1M–$3M+ Healthcare focus: Reproductive and maternal health, chronic conditions, mental health, preventive and consumer health Geographic focus: United States Assets under management: ~$38.5M (legacy RH Capital Fund II); Fund III active, size undisclosed Currently deploying: Yes (Fund III) Notable healthcare portfolio companies:
Ovia Health — maternity and family health platform, acquired by LabCorp
Nurx — telehealth for sexual, reproductive, and dermatologic care
Cirqle Biomedical — non-hormonal, on-demand contraception
Launched in 2024 by the team behind RH Capital / Rhia Ventures, broadening from reproductive health into chronic and preventive care.
2. Portfolia — Women's Health Fund IV
Stage focus: Seed, Series A, Series B Check size range: Not publicly disclosed Healthcare focus: Portfolio spans cardiovascular, bone, autoimmune, and oncology alongside fertility and menopause. Geographic focus: United States Assets under management: Not publicly disclosed, 105 investments in 46 companies Currently deploying: Yes (Fund IV) Notable healthcare portfolio companies:
OsteoBoost — wearable device for bone density and osteoporosis
Maven Clinic — women's and family health; first US women's-health unicorn
Everly Health — at-home diagnostics and lab testing
The most active women's-health investor globally and the broadest in scope.
3. SteelSky Ventures
Stage focus: Seed, Series A Check size range: $500K–$2M Healthcare focus: Access, care, and outcomes across women's health; menopause, cardiovascular, mental health, orthopedics and bone health, and care access Geographic focus: United States Assets under management: ~$72M (latest fund) Currently deploying: Yes Notable healthcare portfolio companies:
Midi Health — virtual menopause, midlife, and longevity care
Movn Health — at-home cardiac rehab and cardiovascular prevention
Bend Health — virtual mental health for women and families
Commons Clinic — women's orthopedics, bone health, and pain management
4. Cross-Border Impact Ventures
Stage focus: Seed, Series A, Series B Check size range: $2.5M–$3M Healthcare focus: Health technology for women, children, and adolescents, diagnostics, devices, and therapeutics Geographic focus: Global Assets under management: $90M+ (inaugural fund) Currently deploying: Yes Notable healthcare portfolio companies:
Sonio — AI-assisted fetal ultrasound and prenatal diagnostics
mOm Incubators — low-cost, transportable infant incubators
OncoLens — oncology care-coordination and knowledge-transfer platform
Canada-based fund backing women's, children's, and adolescent health technology globally.
5. Avestria Ventures
Stage focus: Seed, Series A Check size range: $100-$500k Healthcare focus: Women's health and female-founded life sciences, menopause, cardiovascular, Alzheimer's, and reproductive care Geographic focus: United States Assets under management: $200M Currently deploying: Yes Notable healthcare portfolio companies:
Midi Health — virtual menopause and midlife care
Madorra — non-hormonal device for menopausal women and breast-cancer survivors
Mae — maternal health support for Black mothers
6. Amboy Street Ventures
Stage focus: Seed, Series A Check size range: $500K–$1M Healthcare focus: Women's and sexual health, menopause, hormonal health, LGBTQ+ health, fertility, and contraception Geographic focus: United States / global Assets under management: $20M (debut fund) Currently deploying: Yes Notable healthcare portfolio companies:
Alloy — menopause telehealth and prescription care
HerMD — hybrid clinics for menopause and sexual-health care
Evvy — vaginal microbiome testing and care
Billed as the first VC fund focused on women's health and sexual wellbeing for all genders.
7. Coyote Ventures
Stage focus: Pre-seed, Seed Check size range: $100K–$500K Healthcare focus: Hormonal and metabolic health, menopause, breast and ovarian cancer, diagnostics, and wellness Geographic focus: United States Assets under management: Debut fund (LPs include Bank of America); size not publicly disclosed Currently deploying: Yes Notable healthcare portfolio companies:
Gabbi — breast cancer risk detection and diagnostics
Hera Biotech — non-surgical endometriosis diagnostics
Wile — hormone and perimenopause health for women 40+
Invests across the biological, hormonal, and genetic differences in women's health.
8. Emmeline Ventures
Stage focus: Pre-seed, Seed Check size range: $50K–$500K Healthcare focus: Female founders helping women manage their health, build wealth, and live in a cleaner, safer world Geographic focus: United States Assets under management: Not publicly disclosed Currently deploying: Yes Notable healthcare portfolio companies:
LunaJoy — digital mental-health clinic for women
She Matters — culturally competent postpartum and mental-health care for Black women
Womaness — menopause and midlife wellness
Pairs capital with hands-on operating support: pitch reviews, raise strategy, and operational guidance.
9. Springbank Collective
Stage focus: Pre-seed , Seed, Series A Check size range: $250K–$2M Healthcare focus: Women's health, mental health, caregiving, and family financial wellness Geographic focus: United States Assets under management: $35M Currently deploying: Yes Notable healthcare portfolio companies:
Little Otter — children's and family mental health
Summer Health — pediatric telehealth
Wellthy — caregiving coordination and support
Invests in the infrastructure serving women and working families.
10. Female Founders Fund
Stage focus: Seed Check size range: $500K–$750K Healthcare focus: Women-founded technology, with a deep digital-health and women's-health track record Geographic focus: United States Assets under management: Multiple funds; ~$140M cumulative across four funds (Fund I $6M, Fund II $25M, Fund III $57M, Fund IV $29M) Notable healthcare portfolio companies:
Tia — women's primary and gynecological care
Maven Clinic — women's and family health unicorn
Billie — women's personal care and body health
